Alentis Therapeutics - Company ^Investors

Clinical-stage biotechnology companyВідповідно до джерел: 2Alentis Therapeutics is a clinical-stage biotechnology company focused on developing therapies for cancer and organ fibrosis. The company works on anti-Claudin-1 monoclonal antibodies and antibody-drug conjugates aimed at treating CLDN1+ tumors and fibrotic Therapeutics - Therapeutics, the Claudin-1 (CLDN1) company, is a clinical stage biotechnology company that focuses on developing first-in-class breakthrough treatments for CLDN1+ tumors and organ Therapeutics: